Search Site

Trends banner

Eni profit falls due to dip in oil prices

Q2 net profit fell by 18% to $637 million.

Emirates NBD H1 profit $3.40bn

Total income rose by 12 percent in the same period.

ADIB H1 pre-tax profit $1.08bn

Q2 pre-tax net profit increases by 14 percent.

AstraZeneca to invest $50bn in US

Bulk of funds to go into a Virginia manufacturing center.

UAB net profit up by 50% for H1

Total assets increase by 11 percent.

Nvidia tops $4 trillion as US stocks shrug off latest tariffs

Nvidia tops $4 trillion in market capitalization. (AFP)
  • But stocks pushed higher nonetheless, with Nvidia jumping 2.5 percent to top $4 trillion in market capitalization on investor bullishness over Artificial Intelligence (AI) growth.
  • Briefing.com analyst Patrick O'Hare said investors are not "overly concerned" about Trump's latest tariff threats.

New York, United States — Wall Street stocks bounced early Wednesday following two downcast sessions, shrugging off US President Donald Trump’s latest tariff threats as Nvidia surged to a fresh record.

After Congress gave Trump a big win last week with his fiscal package, the Republican’s aggressive trade posture has returned with a vengeance this week.

On Tuesday, he added threatened levies on copper and pharmaceuticals to a laundry list of countries warned of higher tariffs.

But stocks pushed higher nonetheless, with Nvidia jumping 2.5 percent to top $4 trillion in market capitalization on investor bullishness over Artificial Intelligence (AI) growth.

About 30 minutes into trading, the Dow Jones Industrial Average was up 0.5 percent at 44,477.06.

The broad-based S&P 500 advanced 0.7 percent to 6,266.23, while the tech-rich Nasdaq Composite Index rose 1.1 percent to 20,586.42.

Briefing.com analyst Patrick O’Hare said investors are not “overly concerned” about Trump’s latest tariff threats.

“The assumption, it seems, is that better terms with trading partners of economic consequence will get worked out and that the tariffs won’t be as onerous as advertised from a growth or inflation standpoint,” O’Hare wrote in a note.

Among individual companies, Merck rose 2.5 percent after announcing it reached a deal to acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases for about $10 billion. Verona jumped 20.7 percent.

Later Wednesday, markets will digest minutes from the most recent Federal Reserve meeting, at which central bankers kept interest rates unchanged.